Welcome to our end of the year wrap-up post for The Week in Weed; it’s hard to believe another year has come and (almost) gone, but the calendar doesn’t lie.  In what we are calling an homage to Dave Barry and his always hilarious Year in Review, we’ll organize these stories by month.

Without further ado, here’s a look at the stories that grabbed our attention in 2018. Continue Reading The Week, No Make that the Year, in Weed: 2018

Welcome to the 4/20 edition of Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

It’s been a big week for Republicans embracing legal marijuana or marijuana-related products.  Donald Trump, John Boehner and Mitch McConnell have all moved to embrace the plant.

President Donald Trump will lift his administration’s plans for a possible crackdown on states that have legalized marijuana after talks with a Colorado senator, the White House said on Friday, an action that undercuts U.S. Attorney General Jeff Sessions.

The former House speaker once said he was “unalterably opposed” to legalization. Now, after joining a cannabis company’s board, he is arguing for change.

Today, the Senate Majority Leader has made good on his words. Mitch McConnell has officially filed his promised hemp farming bill.

But it’s not just the Republicans who are giving cannabis a second glance.  Both candidates vying for the Democratic nomination in the New York governor’s race are speaking about legalization.

A week after telling two interviewers her support for legalizing recreational use of marijuana in New York was revenue-based, Democratic candidate for governor Cynthia Nixon said Wednesday that it’s now foremost a racial justice issue for her.

Is the governor paving the way to legalizing recreational marijuana in New York?

In non-political news, it looks like the FDA is going to approve the use of an epilepsy drug made from the marijuana plant.

The medication would treat seizures that typically affect children.

GW Pharma spiked to an 11-week high Tuesday after an internal review hinted at the likelihood the FDA will approve its cannabis-based anti-seizure drug.

Happy 4/20 everyone!  In case you’re wondering about the origins of this celebration, check out Leafly’s article here: The Origin and Meaning of the 4/20 Holiday.